Posted in | News | Molybdenum

NMC Resource Releases High-Grade Assay Results from NMC Moland Mine

NMC Resource has released the excellent assay results of the drilling program at the main zone, which is between the levels 257 m and 217 m in the NMC Moland Mine, South Korea.

The company has completed 36 drill holes, which signifies 2,516 m, in the Main zone expansion and advances to drill further holes to outline the down dip expansions of the main molybdenum mineralized zone. It has encountered high-grade assays from 10 holes that represent 745 m enclosing the deposit’s west part of the Main zone expansion.

The company is expecting the remaining results from 26 holes, totaling 1,771 m in the upcoming weeks. In addition, the Main zone expansion has some inadequate previous samples and drill information.

These assay results assist the occurrence of the excellent molybdenum mineralization beneath the 257 m level. A technical report from NMC Moland Mine, dated October 8, 2009, along with NI 43-101 compliance report covers the deposit over 257 m level. The company has planned to revise the resource estimate for including NMC Moland Mine’s downward extension.

NMC Moland Mine is producing commercially since April 2010 and continues to offer a constant revenue stream for the company. The location of the crushing chamber of NMC Moland Mine is underground, and 100% of the water is reused. This mine does not possess a tailings pond as all the tailings are utilized as material for making cement.

NMC has shipped the pulp to the North Vancouver-based ALS Chemex lab, where the sample was assimilated by four acid solutions and then examined by ICP analysis.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NMC Resource Corporation. (2019, February 18). NMC Resource Releases High-Grade Assay Results from NMC Moland Mine. AZoMining. Retrieved on November 24, 2024 from https://www.azomining.com/News.aspx?newsID=4801.

  • MLA

    NMC Resource Corporation. "NMC Resource Releases High-Grade Assay Results from NMC Moland Mine". AZoMining. 24 November 2024. <https://www.azomining.com/News.aspx?newsID=4801>.

  • Chicago

    NMC Resource Corporation. "NMC Resource Releases High-Grade Assay Results from NMC Moland Mine". AZoMining. https://www.azomining.com/News.aspx?newsID=4801. (accessed November 24, 2024).

  • Harvard

    NMC Resource Corporation. 2019. NMC Resource Releases High-Grade Assay Results from NMC Moland Mine. AZoMining, viewed 24 November 2024, https://www.azomining.com/News.aspx?newsID=4801.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.